GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Accumulated other comprehensive income (loss)

Hemagen Diagnostics (Hemagen Diagnostics) Accumulated other comprehensive income (loss) : $-0.08 Mil (As of Sep. 2012)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Hemagen Diagnostics's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2012 was $-0.08 Mil.

Hemagen Diagnostics's quarterly Accumulated other comprehensive income (loss) declined from Mar. 2012 ($-0.01 Mil) to Jun. 2012 ($-0.10 Mil) but then increased from Jun. 2012 ($-0.10 Mil) to Sep. 2012 ($-0.08 Mil).

Hemagen Diagnostics's annual Accumulated other comprehensive income (loss) declined from Sep. 2010 ($0.02 Mil) to Sep. 2011 ($-0.02 Mil) and declined from Sep. 2011 ($-0.02 Mil) to Sep. 2012 ($-0.08 Mil).


Hemagen Diagnostics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Hemagen Diagnostics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Accumulated other comprehensive income (loss) Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.10 -0.03 0.02 -0.02 -0.08

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.03 -0.01 -0.10 -0.08

Hemagen Diagnostics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Hemagen Diagnostics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines